No profile data available.
Alpha Teknova, Inc. (TKNO) is a healthcare company in the biological analysis equipment industry, based in Hollister, United States, with about 158 full-time employees.
It reported revenue of $40.52 million for fiscal year 2025, up 7.4% from fiscal year 2024, and net income of -$17.26 million. United States was its largest region in fiscal year 2025, with 94% of revenue. Its market capitalization was $474.60 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.
Alpha Teknova reported $40.52 million in revenue for fiscal year 2025, up 7.4% from $37.75 million in fiscal year 2024.
United States: 94% of revenue by region in fiscal year 2025, followed by International (6%).
$474.60 million as of October 9, 2026.
Listed companies of a similar size in the same industry (biological analysis equipment) include Pacific Biosciences of California, Inc. (PACB), Cytek Biosciences, Inc. (CTKB), Standard BioTools Inc. (LAB), Quantum-Si incorporated (QSI).